Home » Sanofi-Aventis, Intelliject Sign Licensing Agreement for Epinephrine Auto Injector
Sanofi-Aventis, Intelliject Sign Licensing Agreement for Epinephrine Auto Injector
Sanofi-aventis U.S. announced Monday the signing of
an exclusive licensing agreement with Intelliject, Inc. for a novel epinephrine auto injector for the emergency treatment of allergic reactions (anaphylaxis)
in North America.
Fox Business
Fox Business
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May